BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Foley PW, Leyva F, Frenneaux MP. What is treatment success in cardiac resynchronization therapy? Europace 2009;11 Suppl 5:v58-65. [PMID: 19861392 DOI: 10.1093/europace/eup308] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Vrtovec B, Poglajen G, Sever M, Zemljic G, Frljak S, Cerar A, Cukjati M, Jaklic M, Cernelc P, Haddad F, Wu JC. Effects of Repetitive Transendocardial CD34 + Cell Transplantation in Patients With Nonischemic Dilated Cardiomyopathy. Circ Res 2018;123:389-96. [DOI: 10.1161/circresaha.117.312170] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
2 Martins S, Carvalheiro T, Laranjeira P, Martinho A, Elvas L, Gonçalves L, Tomaz C, António N, Paiva A. Impact of cardiac resynchronization therapy on circulating IL-17 producing cells in patients with advanced heart failure. J Interv Card Electrophysiol 2019;54:257-65. [PMID: 30483979 DOI: 10.1007/s10840-018-0491-3] [Reference Citation Analysis]
3 Auger DA, Bilchick KC, Gonzalez JA, Cui SX, Holmes JW, Kramer CM, Salerno M, Epstein FH. Imaging left-ventricular mechanical activation in heart failure patients using cine DENSE MRI: Validation and implications for cardiac resynchronization therapy. J Magn Reson Imaging 2017;46:887-96. [PMID: 28067978 DOI: 10.1002/jmri.25613] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
4 Sohaib SA, Chen Z, Whinnett ZI, Bouri S, Dickstein K, Linde C, Hayes DL, Manisty CH, Francis DP. Meta-analysis of symptomatic response attributable to the pacing component of cardiac resynchronization therapy. European Journal of Heart Failure 2013;15:1419-28. [DOI: 10.1093/eurjhf/hft139] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
5 Leyva F. Cardiac resynchronization therapy guided by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010;12:64. [PMID: 21062491 DOI: 10.1186/1532-429X-12-64] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
6 Daly DD Jr, Gold MR. Update on Cardiac Resynchronisation Therapy for Heart Failure. Eur Cardiol 2014;9:100-3. [PMID: 30310494 DOI: 10.15420/ecr.2014.9.2.100] [Reference Citation Analysis]
7 Zusterzeel R, Selzman KA, Sanders WE, O’callaghan KM, Caños DA, Vernooy K, Prinzen FW, Gorgels APM, Strauss DG. Toward Sex-Specific Guidelines for Cardiac Resynchronization Therapy? J of Cardiovasc Trans Res 2016;9:12-22. [DOI: 10.1007/s12265-015-9663-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
8 Zemljic G, Poglajen G, Sever M, Cukjati M, Frljak S, Androcec V, Cernelc P, Haddad F, Vrtovec B. Electroanatomic Properties of the Myocardium Predict Response to CD34+ Cell Therapy in Patients With Ischemic and Nonischemic Heart Failure. Journal of Cardiac Failure 2017;23:153-60. [DOI: 10.1016/j.cardfail.2016.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
9 Rocha EA, Pereira FT, Abreu JS, Lima JW, Monteiro Mde P, Rocha Neto AC, Goés CV, Farias AG, Rodrigues Sobrinho CR, Quidute AR, Scanavacca MI. Development and Validation of Predictive Models of Cardiac Mortality and Transplantation in Resynchronization Therapy. Arq Bras Cardiol 2015;105:399-409. [PMID: 26559987 DOI: 10.5935/abc.20150093] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Nazzal CM, Mulligan LJ, Criscione JC. Efficient characterization of inhomogeneity in contraction strain pattern. Biomech Model Mechanobiol 2012;11:585-93. [PMID: 21927825 DOI: 10.1007/s10237-011-0335-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Paton MF, Gierula J, Lowry JE, Cairns DA, Bose Rosling K, Cole CA, McGinlay M, Straw S, Byrom R, Cubbon RM, Kearney MT, Witte KK. Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trial. PLoS One 2021;16:e0259450. [PMID: 34898655 DOI: 10.1371/journal.pone.0259450] [Reference Citation Analysis]
12 Ricci F, Mele D, Bianco F, Bucciarelli V, De Caterina R, Gallina S. Right heart-pulmonary circulation unit and cardiac resynchronization therapy. Am Heart J 2017;185:1-16. [PMID: 28267462 DOI: 10.1016/j.ahj.2016.11.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
13 Tomini F, Prinzen F, van Asselt AD. A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure. Eur J Health Econ 2016;17:1159-72. [PMID: 26728985 DOI: 10.1007/s10198-015-0752-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Brugada J, Brachmann J, Delnoy PP, Padeletti L, Reynolds D, Ritter P, Borri-Brunetto A, Singh JP. Automatic optimization of cardiac resynchronization therapy using SonR-rationale and design of the clinical trial of the SonRtip lead and automatic AV-VV optimization algorithm in the paradym RF SonR CRT-D (RESPOND CRT) trial. Am Heart J 2014;167:429-36. [PMID: 24655689 DOI: 10.1016/j.ahj.2013.12.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
15 Gierula J, Cubbon RM, Jamil HA, Byrom R, Baxter PD, Pavitt S, Gilthorpe MS, Hewison J, Kearney MT, Witte KK. Cardiac resynchronization therapy in pacemaker-dependent patients with left ventricular dysfunction. Europace. 2013;15:1609-1614. [PMID: 23736807 DOI: 10.1093/europace/eut148] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
16 Loring Z, Friedman DJ, Emerek K, Graff C, Sørensen PL, Hansen SM, Wieslander B, Ugander M, Søgaard P, Atwater BD. Lead one ratio in left bundle branch block predicts poor cardiac resynchronization therapy response. Pacing Clin Electrophysiol 2020;43:503-10. [PMID: 32285950 DOI: 10.1111/pace.13916] [Reference Citation Analysis]
17 Gierula J, Jamil HA, Byrom R, Joy ER, Cubbon RM, Kearney MT, Witte KK. Pacing-associated left ventricular dysfunction? Think reprogramming first! Heart 2014;100:765-9. [DOI: 10.1136/heartjnl-2013-304905] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
18 Sieniewicz BJ, Gould J, Porter B, Sidhu BS, Behar JM, Claridge S, Niederer S, Rinaldi CA. Optimal site selection and image fusion guidance technology to facilitate cardiac resynchronization therapy. Expert Rev Med Devices 2018;15:555-70. [PMID: 30019954 DOI: 10.1080/17434440.2018.1502084] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
19 Arora S, Aarones M, Aakhus S, Skaardal R, Aass H, Aukrust P, Kongsgaard E, Gullestad L. Peak oxygen uptake during cardiopulmonary exercise testing determines response to cardiac resynchronization therapy. Journal of Cardiology 2012;60:228-35. [DOI: 10.1016/j.jjcc.2012.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Poglajen G, Sever M, Cukjati M, Cernelc P, Knezevic I, Zemljic G, Haddad F, Wu JC, Vrtovec B. Effects of transendocardial CD34+ cell transplantation in patients with ischemic cardiomyopathy. Circ Cardiovasc Interv. 2014;7:552-559. [PMID: 25097199 DOI: 10.1161/circinterventions.114.001436] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
21 Delnoy PP, Ritter P, Naegele H, Orazi S, Szwed H, Zupan I, Goscinska-Bis K, Anselme F, Martino M, Padeletti L. Association between frequent cardiac resynchronization therapy optimization and long-term clinical response: a post hoc analysis of the Clinical Evaluation on Advanced Resynchronization (CLEAR) pilot study. Europace 2013;15:1174-81. [PMID: 23493410 DOI: 10.1093/europace/eut034] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
22 Fazio S, Carlomagno G. The importance of tricuspid regurgitation and right ventricular overload in ICD/CRT recipients: beside the left, beyond the left. Pacing Clin Electrophysiol 2011;34:1181-4. [PMID: 21819432 DOI: 10.1111/j.1540-8159.2011.03189.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
23 Rocha EA, Pereira FT, Abreu JS, Lima JW, Monteiro Mde P, Rocha Neto AC, Quidute AR, Goés CV, Rodrigues Sobrinho CR, Scanavacca MI. Echocardiographic Predictors of Worse Outcome After Cardiac Resynchronization Therapy. Arq Bras Cardiol 2015;105:552-9. [PMID: 26351981 DOI: 10.5935/abc.20150108] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Ritter P, Delnoy PP, Padeletti L, Lunati M, Naegele H, Borri-Brunetto A, Silvestre J. A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. Europace. 2012;14:1324-1333. [PMID: 22549295 DOI: 10.1093/europace/eus059] [Cited by in Crossref: 82] [Cited by in F6Publishing: 53] [Article Influence: 8.2] [Reference Citation Analysis]
25 Shanmugam N, Campos AG, Prada-delgado O, Bizrah M, Valencia O, Jones S, Collinson P, Anderson L. Effect of atrioventricular optimization on circulating N-terminal pro brain natriuretic peptide following cardiac resynchronization therapy. European Journal of Heart Failure 2013;15:534-42. [DOI: 10.1093/eurjhf/hft012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
26 Zusterzeel R. Safety and Effectiveness of Medical Device Therapy. In: Kerkhof PLM, Miller VM, editors. Sex-Specific Analysis of Cardiovascular Function. Cham: Springer International Publishing; 2018. pp. 107-21. [DOI: 10.1007/978-3-319-77932-4_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Almeida-Morais L, Abreu A, Oliveira M, Silva Cunha P, Rodrigues I, Portugal G, Rio P, Soares R, Mota Carmo M, Cruz Ferreira R. Impact of cardiac resynchronization therapy on inflammatory biomarkers and cardiac remodeling: The paradox of functional and echocardiographic response. Rev Port Cardiol (Engl Ed) 2018;37:105-13. [PMID: 29503051 DOI: 10.1016/j.repc.2017.06.017] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
28 Karaca O, Gunes HM, Omaygenc MO, Cakal B, Cakal SD, Demir GG, Kizilirmak F, Gokdeniz T, Barutcu I, Boztosun B, Kilicaslan F. Predicting Ventricular Arrhythmias in Cardiac Resynchronization Therapy: The Impact of Persistent Electrical Dyssynchrony. Pacing Clin Electrophysiol 2016;39:969-77. [PMID: 27333978 DOI: 10.1111/pace.12908] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
29 Menet A, Guyomar Y, Ennezat P, Graux P, Castel AL, Delelis F, Heuls S, Cuvelier E, Gevaert C, Le Goffic C, Tribouilloy C, Maréchaux S. Prognostic value of left ventricular reverse remodeling and performance improvement after cardiac resynchronization therapy: A prospective study. International Journal of Cardiology 2016;204:6-11. [DOI: 10.1016/j.ijcard.2015.11.091] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
30 Singh JP, Abraham WT, Auricchio A, Delnoy PP, Gold M, Reddy VY, Sanders P, Lindenfeld J, Rinaldi CA. Design and rationale for the Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in non-responders and previously untreatable patients (SOLVE-CRT) trial. Am Heart J 2019;217:13-22. [PMID: 31472360 DOI: 10.1016/j.ahj.2019.04.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
31 Khamzin S, Dokuchaev A, Bazhutina A, Chumarnaya T, Zubarev S, Lyubimtseva T, Lebedeva V, Lebedev D, Gurev V, Solovyova O. Machine Learning Prediction of Cardiac Resynchronisation Therapy Response From Combination of Clinical and Model-Driven Data. Front Physiol 2021;12:753282. [PMID: 34970154 DOI: 10.3389/fphys.2021.753282] [Reference Citation Analysis]
32 Auger D, van Bommel RJ, Bertini M, Delgado V, Ng AC, Ewe SH, Shanks M, Marsan NA, Mooyaart EA, Witkowski T, Poldermans D, Schalij MJ, Bax JJ. Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy. Am Heart J 2010;160:737-43. [PMID: 20934569 DOI: 10.1016/j.ahj.2010.07.016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
33 Gierula J, Witte KKA. Response to (resynchronization) therapy in chronic heart failure: time for a different approach: Response to resynchronization therapy in heart failure patients. Eur J Heart Fail 2014;16:117-8. [DOI: 10.1002/ejhf.53] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
34 Padeletti L, Paoletti Perini A, Gronda E. Cardiac resynchronization therapy: the issue of non-response. Heart Fail Rev 2012;17:97-105. [PMID: 21533977 DOI: 10.1007/s10741-011-9250-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
35 AlTurki A, Lima PY, Bernier ML, Garcia D, Vidal A, Toscani B, Diaz S, Montemezzo M, Al-Dossari A, Hadjis T, Joza J, Essebag V. Optimization of Chronic Cardiac Resynchronization Therapy Using Fusion Pacing Algorithm Improves Echocardiographic Response. CJC Open 2020;2:62-70. [PMID: 32190827 DOI: 10.1016/j.cjco.2019.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 McFarlane NJ, Lin X, Zhao Y, Clapworthy GJ, Dong F, Redaelli A, Parodi O, Testi D. Visualization and simulated surgery of the left ventricle in the virtual pathological heart of the Virtual Physiological Human. Interface Focus 2011;1:374-83. [PMID: 22670207 DOI: 10.1098/rsfs.2010.0040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Tobon-Gomez C, Duchateau N, Sebastian R, Marchesseau S, Camara O, Donal E, De Craene M, Pashaei A, Relan J, Steghofer M, Lamata P, Delingette H, Duckett S, Garreau M, Hernandez A, Rhode KS, Sermesant M, Ayache N, Leclercq C, Razavi R, Smith NP, Frangi AF. Understanding the mechanisms amenable to CRT response: from pre-operative multimodal image data to patient-specific computational models. Med Biol Eng Comput 2013;51:1235-50. [PMID: 23430328 DOI: 10.1007/s11517-013-1044-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
38 Baur LH. Echocardiography as a guidance in CRT management: the GPS system in a labyrinth? Int J Cardiovasc Imaging 2010;26:193-5. [PMID: 20033489 DOI: 10.1007/s10554-009-9555-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 van 't Sant J, Mast TP, Bos MM, Ter Horst IA, van Everdingen WM, Meine M, Cramer MJ. Echo response and clinical outcome in CRT patients. Neth Heart J 2016;24:47-55. [PMID: 26643303 DOI: 10.1007/s12471-015-0767-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
40 Kuznetsov VA, Soldatova AM, Enina TN, Krinochkin DV, Dyachkov SM. [Does the lack of left ventricular reverse remodeling always mean non - response to cardiac resynchronization therapy?]. Ter Arkh 2019;91:10-5. [PMID: 32598583 DOI: 10.26442/00403660.2019.12.000102] [Reference Citation Analysis]
41 Lang NN, Badar AA, Pettit SJ, Templeton S, Connelly DT, Gardner RS. Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronization therapy. Biomark Med 2014;8:797-806. [PMID: 25224936 DOI: 10.2217/bmm.13.159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Mele D, Bertini M, Malagù M, Nardozza M, Ferrari R. Current role of echocardiography in cardiac resynchronization therapy. Heart Fail Rev 2017;22:699-722. [PMID: 28714039 DOI: 10.1007/s10741-017-9636-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
43 Witte KK, Byrom R. Micronutrients for chronic heart failure: end of the road or path to enlightenment? JACC Heart Fail 2014;2:318-20. [PMID: 24952701 DOI: 10.1016/j.jchf.2014.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
44 Boidol J, Średniawa B, Kowalski O, Szulik M, Mazurek M, Sokal A, Pruszkowska-skrzep P, Kukulski T, Kalarus Z, Lenarczyk R; for the Triple-Site Versus Standard Cardiac Resynchronisation Trial (TRUST CRT) Investigators. Many response criteria are poor predictors of outcomes after cardiac resynchronization therapy: validation using data from the randomized trial. EP Europace 2013;15:835-44. [DOI: 10.1093/europace/eus390] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
45 Behar JM, Claridge S, Jackson T, Sieniewicz B, Porter B, Webb J, Rajani R, Kapetanakis S, Carr-white G, Rinaldi CA. The role of multi modality imaging in selecting patients and guiding lead placement for the delivery of cardiac resynchronization therapy. Expert Review of Cardiovascular Therapy 2017;15:93-107. [DOI: 10.1080/14779072.2016.1252674] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
46 Khurwolah MR, Yao J, Kong XQ. Adverse Consequences of Right Ventricular Apical Pacing and Novel Strategies to Optimize Left Ventricular Systolic and Diastolic Function. Curr Cardiol Rev 2019;15:145-55. [PMID: 30499419 DOI: 10.2174/1573403X15666181129161839] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
47 Rinkuniene D, Bucyte S, Ceseviciute K, Abramavicius S, Baronaite-Dudoniene K, Laukaitiene J, Kazakevicius T, Zabiela V, Sileikis V, Puodziukynas A, Jurkevicius R. Predictors of positive response to cardiac resynchronization therapy. BMC Cardiovasc Disord 2014;14:55. [PMID: 24779476 DOI: 10.1186/1471-2261-14-55] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
48 Duchateau N, Doltra A, Silva E, De Craene M, Piella G, Castel MÁ, Mont L, Brugada J, Frangi AF, Sitges M. Atlas-Based Quantification of Myocardial Motion Abnormalities: Added-Value for Understanding the Effect of Cardiac Resynchronization Therapy. Ultrasound in Medicine & Biology 2012;38:2186-97. [DOI: 10.1016/j.ultrasmedbio.2012.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
49 Pennell DJ, Firmin DN, Kilner PJ, Manning WJ, Mohiaddin RH, Neubauer S, Prasad SK. Review of Journal of Cardiovascular Magnetic Resonance 2009. J Cardiovasc Magn Reson 2010;12:15. [PMID: 20302618 DOI: 10.1186/1532-429X-12-15] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]